Cited by 194Glycosylation and Glycoproteins ResearchProteoglycans and glycosaminoglycans researchCarbohydrate Chemistry and Synthesis

Mucins: Structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets

Dhanisha, Suresh Sulekha, Guruvayoorappan, Chandrasekharan, Drishya, Sudarsanan, Abeesh, Prathapan·2018·Critical Reviews in Oncology/Hematology

Abstract

Mucins are the main structural components of mucus that create a selective protective barrier for epithelial surface and also execute wide range of other physiological functions. Mucins can be classified into two types, namely secreted mucins and membrane bounded mucins. Alterations in mucin expression or glycosylation and mislocalization have been seen in various types of pathological conditions such as cancers, inflammatory bowel disease and ocular disease, which highlight the importance of mucin in maintaining homeostasis. Hence mucins can be used as attractive target for therapeutic intervention. In this review, we discuss in detail about the structural diversity of mucins; their biosynthesis; its role in pathogenesis; regulation and as possible therapeutic targets.

Integrity signals

Registry

Crossref · 10.1016/j.critrevonc.2017.12.006

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dhanisha, S. S., Guruvayoorappan, C., Drishya, S., & Abeesh, P.
Affiliations
Regional Cancer Center, Thiruvananthapuram (IN)
Corresponding author
Guruvayoorappan, Chandrasekharan
Venue
Critical Reviews in Oncology/Hematology
Publisher
Elsevier BV
Published
2018-02
Volume
122
Pages
98-122
ISSN
1040-8428 (ISSN-L)
OpenAlex
W2776567026
Cited by
194
References
4
Citations by year
2026: 24 · 2025: 24 · 2024: 28 · 2023: 23 · 2022: 19 · 2021: 23 · 2020: 23 · 2019: 22 · 2018: 8
FWCI
1.36
Type
journal article
Language
en
Open access
closed
Locations
  • Critical Reviews in Oncology/Hematology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
  • Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
Keywords
mucin, mucus, mucin production, mucin glycosylation, secreted mucins, membrane-bound mucins, epithelial barrier function, cancer, inflammatory bowel disease, eye diseases
MeSH terms
Animals, Humans, Mucins, Neoplasms, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review